Guillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus Trametinib
Küçük Resim Yok
Tarih
2024
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Galenos Publishing House
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
[No abstract available]
Açıklama
Anahtar Kelimeler
Antineoplastic Agents, Female, Guillain-Barre Syndrome, Humans, Imidazoles, Male, Melanoma, Middle Aged, Oximes, Pyridones, Pyrimidinones, B Raf kinase, dabrafenib, fluorodeoxyglucose f 18, glutamic acid, trametinib, valine, antineoplastic agent, dabrafenib, dipyrone, imidazole derivative, oxime, pyrimidinone derivative, trametinib, adult, axillary lymph node dissection, axillary lymph node metastasis, BRAF gene, cancer adjuvant therapy, cancer surgery, case report, clinical article, congenital nevus, drug withdrawal, dysphagia, echography, electromyography, excisional biopsy, facial droop, facial nerve paralysis, follow up, gene mutation, Guillain Barre syndrome, histopathology, human, human tissue, Letter, limb weakness, lumbar puncture, male, melanoma, middle aged, physical examination, plasmapheresis, positron emission tomography-computed tomography, reoperation, sentinel lymph node biopsy, tumor volume, drug therapy, female, Guillain Barre syndrome, melanoma
